Efficacy of Buccal Pad of Fat, Advanced Platelet Rich Fibrin, Fibrin Glue and Oxidized Cellulose Plug in Management of Oro-Antral Communication, Comparative Clinical Study

Healthy Volunteers Only Clinical Trial

— OAC  

Official title:

Efficacy of Buccal Pad of Fat, Advanced Platelet Rich Fibrin, Fibrin Glue and Oxidized Cellulose Plug in Management of Oro-Antral Communication, Comparative Clinical Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06220877
• Other study ID #: RECO6U/19-2020
• Status: Completed
• Phase: N/A
• Start date: January 1, 2019
• Est. completion date: June 1, 2023

Study information

• Verified date: January 2024
• Source: October 6 University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Evaluation of the efficacy of different treatment protocols in the management of Oro-Antral Communications.

Description:

the current study was carried on 24 patients suffering from Oro-Antral Communications. All patients were divided into 4 equal groups.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: June 1, 2023
• Est. primary completion date: January 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years to 50 Years

Eligibility

Inclusion Criteria:

• patients suffering from oroantral communications
• patients suffering from oroantral fistula.
• The Diameter of the opening ranged from 4-9 mm,
• communication resulted from recent extraction,
• foreign body; or
• cyst enucleation Exclusion Criteria: Patients suffering from any systemic diseases were excluded from the study.
• diabetes,
• autoimmune diseases,
• cancers,
• nephropathy,
• coagulation disorders

Related Conditions & MeSH terms

• Healthy Volunteers Only

Intervention

Procedure:
• Buccal Pad of Fat
surgical procedure
• A-PRF
blood sample
• fibrin glue
procedure
• oxidized cellulose
procedure

Locations

Country	Name	City	State
Egypt	October 6U	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
October 6 University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	o Recurrence	presence or absence	6 months
Secondary	pain, visual analog scale	0 no pain, 10 severe pain	4 weeks